Vaxcyte Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Vaxcyte stock has a consensus rating of "Strong Buy" and an average price target of $109. The average 1-year stock price forecast is 121.05% higher than the current stock price, while the lowest is $67 (+35.88%) and the highest is $163 (+230.56%).

Price Target: $109 (+121.05%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$67	$109	$110	$163
Change	+35.88%	+121.05%	+123.08%	+230.56%

Analyst Ratings

The average analyst rating for Vaxcyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	9	9	9	9	9	9
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Seamus Fernandez Guggenheim	Guggenheim	Buy Maintains $116	Buy	Maintains	$116	+135.25%	Jun 3, 2026
Salim Syed Mizuho Securities	Mizuho Securities	Buy Initiates $163	Buy	Initiates	$163	+230.56%	Jun 3, 2026
Umer Raffat Evercore ISI	Evercore ISI	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 21, 2026
Jason Gerberry Bank of America Securities	Bank of America Securities	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 7, 2026
Joseph Stringer Needham	Needham	Buy Reiterates $110	Buy	Reiterates	$110	+123.08%	May 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

87.15M

EPS This Year

-8.48

from -5.63

EPS Next Year

-7.42

from -8.48

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Gross Profit	-	-23.00M	-75.00M	-	-	-
Operating Income	-103.67M	-232.26M	-468.04M	-569.55M	-923.68M	-1.29B
Net Income	-100.08M	-223.49M	-402.27M	-463.93M	-766.63M	-1.23B
EPS	-	-	-	-	-5.63	-8.48
Free Cash Flow	-88.16M	-107.53M	-202.41M	-403.44M	-430.85M	-1.20B
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-8.48
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-